会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • Compositions for affecting weight loss
    • 用于影响减肥的组合物
    • US20070117827A1
    • 2007-05-24
    • US11492685
    • 2006-07-24
    • Gary TollefsonAnthony McKinneyMichelle HigginJohn McCall
    • Gary TollefsonAnthony McKinneyMichelle HigginJohn McCall
    • A61K31/485A61K31/165
    • A61K31/137A61K31/138A61K31/165A61K31/485A61K45/06A61K2300/00
    • Disclosed are compositions for affecting weight loss comprising a first compound and a second compound, where the first compound is a metabolite of naltrexone, such as 6-β-naltrexol or a prodrug of a naltrexone metabolite, and the second compound causes increased agonism of a melanocortin 3 receptor (MC3-R) and/or a melanocortin 4 receptor (MC4-R), and/or increases the concentration of α-MSH in the central nervous system. Also disclosed are methods of affecting weight loss, increasing energy expenditure, increasing satiety in an individual, or suppressing the appetite of an individual, comprising identifying an individual in need thereof and treating that individual to antagonize opioid receptor activity with a metabolite of naltrexone, such as 6-β-naltrexol or a prodrug of a naltrexone metabolite, and treating that individual to enhance α-MSH activity, e.g., by administration of a second compound causes increased agonism of MC3-R and/or MC4-R, and/or increases the concentration of α-MSH in the central nervous system.
    • 公开了用于影响体重减轻的组合物,其包含第一化合物和第二化合物,其中第一化合物是纳曲酮的代谢物,例如6-β-纳曲酮或纳曲酮代谢物的前药,并且所述第二化合物导致增加的激动 黑皮质素3受体(MC3-R)和/或黑皮质素4受体(MC4-R),和/或增加中枢神经系统中α-MSH的浓度。 还公开了影响体重减轻,增加能量消耗,增加个体饱腹感或抑制个体食欲的方法,其包括确定有需要的个体,并用纳曲酮代谢物治疗该个体以拮抗阿片受体活性, 作为6-β-纳曲酮或纳曲酮代谢物的前药,并且例如通过施用第二化合物治疗该个体以增强α-MSH活性,导致MC3-R和/或MC4-R的激动作用增加,和/或 增加中枢神经系统中α-MSH的浓度。